Subcellular Localization Determines the Stability and Axon Protective Capacity of Axon Survival Factor Nmnat2

PLoS Biology

Volumn 11, Issue 4, 2013, Pages

  Milde, Stefan ^a   Gilley, Jonathan ^a   Coleman, Michael P ^a  

^a BABRAHAM INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE;

ARTICLE; CELLULAR DISTRIBUTION; EXON; HUMAN; LYSOSOME; MITOCHONDRION; NERVE DEGENERATION; NERVE FIBER; NERVE FIBER TRANSPORT; NEURITE; PALMITOYLATION; PROTEIN STABILITY; SURVIVAL FACTOR; SYNAPSE VESICLE; TRANS GOLGI NETWORK;

AMINO ACID MOTIFS; ANIMALS; AXONS; CELL SURVIVAL; CELLS, CULTURED; EXONS; GOLGI APPARATUS; HALF-LIFE; INTRACELLULAR MEMBRANES; LIPOYLATION; MICE; MICE, INBRED C57BL; NEURONS; NICOTINAMIDE-NUCLEOTIDE ADENYLYLTRANSFERASE; PRIMARY CELL CULTURE; PROTEIN MULTIMERIZATION; PROTEIN STABILITY; PROTEIN TRANSPORT; SINGLE-CELL ANALYSIS; TIME-LAPSE IMAGING; TRANSPORT VESICLES; UBIQUITINATION;

WALLERIA;

EID: 84876987935     PISSN: 15449173     EISSN: 15457885     Source Type: Journal    
DOI: 10.1371/journal.pbio.1001539     Document Type: Article

References (56)

1. Conforti L, Fang G, Beirowski B, Wang MS, Sorci L, et al. (2007) NAD(+) and axon degeneration revisited: Nmnat1 cannot substitute for Wld(S) to delay Wallerian degeneration. Cell Death Differ 14: 116-127 Available: http://www.ncbi.nlm.nih.gov/pubmed/16645633.
2. Mack TG, Reiner M, Beirowski B, Mi W, Emanuelli M, et al. (2001) Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. Nat Neurosci 4: 1199-1206 Available: http://www.ncbi.nlm.nih.gov/pubmed/11770485.
3. Wang M, Wu Y, Culver DG, Glass JD, (2001) The gene for slow Wallerian degeneration (Wld(s)) is also protective against vincristine neuropathy. Neurobiol Dis 8: 155-161 Available: http://www.ncbi.nlm.nih.gov/pubmed/11162249.
4. Wang MS, Davis AA, Culver DG, Glass JD, (2002) WldS mice are resistant to paclitaxel (taxol) neuropathy. Ann Neurol 52: 442-447 Available: http://www.ncbi.nlm.nih.gov/pubmed/12325073.
5. Ferri A, Sanes JR, Coleman MP, Cunningham JM, Kato AC, (2003) Inhibiting axon degeneration and synapse loss attenuates apoptosis and disease progression in a mouse model of motoneuron disease. Curr Biol 13: 669-673 Available: http://www.ncbi.nlm.nih.gov/pubmed/12699624.
6. Mi W, Beirowski B, Gillingwater TH, Adalbert R, Wagner D, et al. (2005) The slow Wallerian degeneration gene, WldS, inhibits axonal spheroid pathology in gracile axonal dystrophy mice. Brain 128: 405-416 Available: http://www.ncbi.nlm.nih.gov/pubmed/15644421.
7. Hasbani DM, O'Malley KL, (2006) Wld(S) mice are protected against the Parkinsonian mimetic MPTP. Exp Neurol 202: 93-99 Available: http://www.ncbi.nlm.nih.gov/pubmed/16806180.
8. Sajadi A, Schneider BL, Aebischer P, (2004) Wlds-mediated protection of dopaminergic fibers in an animal model of Parkinson disease. Curr Biol 14: 326-330 Available: http://www.ncbi.nlm.nih.gov/pubmed/14972684.
9. Samsam M, Mi W, Wessig C, Zielasek J, Toyka K V, et al. (2003) The Wlds mutation delays robust loss of motor and sensory axons in a genetic model for myelin-related axonopathy. J Neurosci 23: 2833-2839 Available: http://www.ncbi.nlm.nih.gov/pubmed/12684470.
10. Conforti L, Wilbrey A, Morreale G, Janeckova L, Beirowski B, et al. (2009) Wld S protein requires Nmnat activity and a short N-terminal sequence to protect axons in mice. J Cell Biol 184: 491-500 Available: http://www.ncbi.nlm.nih.gov/pubmed/19237596.
11. Avery M a, Sheehan AE, Kerr KS, Wang J, Freeman MR, (2009) Wld S requires Nmnat1 enzymatic activity and N16-VCP interactions to suppress Wallerian degeneration. J Cell Biol 184: 501-513 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2654119&tool=pmcentrez&rendertype=abstract. Accessed 27 July 2011.
12. Beirowski B, Babetto E, Gilley J, Mazzola F, Conforti L, et al. (2009) Non-nuclear Wld(S) determines its neuroprotective efficacy for axons and synapses in vivo. J Neurosci 29: 653-668 Available: http://www.ncbi.nlm.nih.gov/pubmed/19158292.
13. Gilley J, Coleman MP, (2010) Endogenous Nmnat2 is an essential survival factor for maintenance of healthy axons. PLoS Biol 8: e1000300 Available: http://dx.plos.org/10.1371/journal.pbio.1000300. doi:10.1371/journal.pbio.1000300.
14. Yan T, Feng Y, Zheng J, Ge X, Zhang Y, et al. (2010) Nmnat2 delays axon degeneration in superior cervical ganglia dependent on its NAD synthesis activity. Neurochem Int 56: 101-106 Available: http://www.ncbi.nlm.nih.gov/pubmed/19778564.
15. Feng Y, Yan T, Zheng J, Ge X, Mu Y, et al. (2010) Overexpression of Wld(s) or Nmnat2 in mauthner cells by single-cell electroporation delays axon degeneration in live zebrafish. Neurosci Res 88: 3319-33127 Available: http://www.ncbi.nlm.nih.gov/pubmed/20857515. Accessed 27 September 2010.
16. Ljungberg MC, Ali YO, Zhu J, Wu C-S, Oka K, et al. (2012) CREB-activity and nmnat2 transcription are down-regulated prior to neurodegeneration, while NMNAT2 over-expression is neuroprotective, in a mouse model of human tauopathy. Hum Mol Genet 21: 251-267 Available: http://www.ncbi.nlm.nih.gov/pubmed/22027994. Accessed 3 January 2012.
17. Fang Y, Soares L, Teng X, Geary M, Bonini NM, (2012) A novel Drosophila model of nerve injury reveals an essential role of Nmnat in maintaining axonal integrity. Curr Biol 22: 590-595 Available: http://www.ncbi.nlm.nih.gov/pubmed/22425156. Accessed 27 March 2012.
18. Matsuda W, Furuta T, Nakamura KC, Hioki H, Fujiyama F, et al. (2009) Single nigrostriatal dopaminergic neurons form widely spread and highly dense axonal arborizations in the neostriatum. J Neurosci 29: 444-453 Available: http://www.ncbi.nlm.nih.gov/pubmed/19144844. Accessed 12 March 2012.
19. Jung H, O'Hare CM, Holt CE, (2011) Translational regulation in growth cones. Curr Opin Genet Dev 21: 458-464 Available: http://www.ncbi.nlm.nih.gov/pubmed/21530230. Accessed 11 August 2011.
20. Swanger SA, Bassell GJ, (2011) Making and breaking synapses through local mRNA regulation. Curr Opin Genet Dev 21: 414-421 Available: http://www.ncbi.nlm.nih.gov/pubmed/21530231. Accessed 14 July 2011.
21. Liu-Yesucevitz L, Bassell GJ, Gitler a D, Hart a C, Klann E, et al. (2011) Local RNA translation at the synapse and in disease. J Neurosci 31: 16086-16093 Available: http://www.jneurosci.org/cgi/doi/10.1523/JNEUROSCI.4105-11.2011. Accessed 10 November 2011.
22. De Vos KJ, Grierson AJ, Ackerley S, Miller CCJ, (2008) Role of axonal transport in neurodegenerative diseases. Annu Rev Neurosci 31: 151-173 Available: http://www.annualreviews.org/doi/full/10.1146/annurev.neuro.31.061307.090711. Accessed 7 November 2010.
23. Gumy LF, Yeo GSH, Tung Y-CL, Zivraj KH, Willis D, et al. (2011) Transcriptome analysis of embryonic and adult sensory axons reveals changes in mRNA repertoire localization. RNA 17: 85-98 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3004069&tool=pmcentrez&rendertype=abstract. Accessed 10 March 2012.
24. Willis D, Li KW, Zheng J-Q, Chang JH, Smit AB, et al. (2005) Differential transport and local translation of cytoskeletal, injury-response, and neurodegeneration protein mRNAs in axons. J Neurosci 25: 778-791 Available: http://www.ncbi.nlm.nih.gov/pubmed/15673657. Accessed 14 March 2012.
25. Poon MM, Choi S-H, Jamieson C a M, Geschwind DH, Martin KC, (2006) Identification of process-localized mRNAs from cultured rodent hippocampal neurons. J Neurosci 26: 13390-13399 Available: http://www.ncbi.nlm.nih.gov/pubmed/17182790. Accessed 15 April 2012.
26. Zivraj KH, Tung YCL, Piper M, Gumy L, Fawcett JW, et al. (2010) Subcellular profiling reveals distinct and developmentally regulated repertoire of growth cone mRNAs. J Neurosci 30: 15464-15478 Available: http://www.ncbi.nlm.nih.gov/pubmed/21084603. Accessed 26 March 2012.
27. Mayer PR, Huang N, Dewey CM, Dries DR, Zhang H, et al. (2010) Expression, localization and biochemical characterization of NMN adenylyltransferase 2. J Biol Chem 285: 40387-40396 Available: http://www.jbc.org/cgi/doi/10.1074/jbc.M110.178913. Accessed 14 October 2010.
28. Lau C, Doelle C, Gossmann TI, Agledal L, Niere M, et al. (2010) Isoform-specific targeting and interaction domains (ISTIDs) in human nicotinamide mononucleotide adenylyltransferases (NMNATs). J Biol Chem 3: 18868-18876 Available: http://www.ncbi.nlm.nih.gov/pubmed/20388704.
29. Patterson GH, Lippincott-Schwartz J, (2002) A photoactivatable GFP for selective photolabeling of proteins and cells. Science 297: 1873-1877 Available: http://www.ncbi.nlm.nih.gov/pubmed/12228718.
30. Nenninger A, Mastroianni G, Mullineaux CW, (2010) Size dependence of protein diffusion in the cytoplasm of Escherichia coli. J Bacteriol 192: 4535-4540 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2937421&tool=pmcentrez&rendertype=abstract. Accessed 14 March 2012.
31. Liu Y, Fisher DA, Storm DR, (1993) Analysis of the palmitoylation and membrane targeting domain of neuromodulin (GAP-43) by site-specific mutagenesis. Biochemistry 32: 10714-10719 Available: http://www.ncbi.nlm.nih.gov/pubmed/8399217.
32. Liu Y, Liu, YFisher A, Fisher A, Storm R, (1994) Intracellular sorting of neuromodulin (GAP-43) mutants modified in the membrane targeting domain. J Neurosci 14: 5807-5817.
33. Liang X, Lu Y, Neubert TA, Resh MD, (2002) Mass spectrometric analysis of GAP-43/neuromodulin reveals the presence of a variety of fatty acylated species. J Biol Chem 277: 33032-33040 Available: http://www.ncbi.nlm.nih.gov/pubmed/12105219.
34. Scott DA, Das U, Tang Y, Roy S, (2011) Mechanistic logic underlying the axonal transport of cytosolic proteins. Neuron 70: 441-454 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3096075&tool=pmcentrez&rendertype=abstract. Accessed 22 July 2011.
35. Brunetti L, Distefano M, Ruggieri S, Cimadamore F, Magni G, (2010) Homology modeling and deletion mutants of human nicotinamide mononucleotide adenylyltransferase isozyme 2: New insights on structure and function relationship. Protein Sci 19: 2440-2450 Available: http://www.ncbi.nlm.nih.gov/pubmed/20954240. Accessed 20 October 2010.
36. Yalowitz J a, Xiao S, Biju MP, Antony AC, Cummings OW, et al. (2004) Characterization of human brain nicotinamide 5′-mononucleotide adenylyltransferase-2 and expression in human pancreas. Biochem J 377: 317-326 Available: http://www.ncbi.nlm.nih.gov/pubmed/14516279.
37. Cai Y, Yu S-S, Chen S-R, Pi R-B, Gao S, et al. (2012) Nmnat2 protects cardiomyocytes from hypertrophy via activation of SIRT6. FEBS Lett 586: 866-874 Available: http://www.ncbi.nlm.nih.gov/pubmed/22449973. Accessed 9 May 2012.
38. Wiggins CM, Tsvetkov P, Johnson M, Joyce CL, Lamb C a, et al. (2011) BIM(EL), an intrinsically disordered protein, is degraded by 20S proteasomes in the absence of poly-ubiquitylation. J Cell Sci 124: 969-977 Available: http://www.ncbi.nlm.nih.gov/pubmed/21378313. Accessed 14 March 2012.
39. Wiggins CM, Johnson M, Cook SJ, (2010) Refining the minimal sequence required for ERK1/2-dependent poly-ubiquitination and proteasome-dependent turnover of BIM. Cell Signal 22: 801-808 Available: http://www.ncbi.nlm.nih.gov/pubmed/20074640.
40. Muthuswamy S, (1999) Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo-and heterodimers. Mol Cell Biol 19: 6845-6857 Available: http://mcb.asm.org/content/19/10/6845.short. Accessed 25 July 2012.
41. Di Lisa F, Ziegler M, (2001) Pathophysiological relevance of mitochondria in NAD(+) metabolism. FEBS Lett 492: 4-8 Available: http://www.ncbi.nlm.nih.gov/pubmed/11248227.
42. Skene J, Virag I, (1989) Posttranslational membrane attachment and dynamic fatty acylation of a neuronal growth cone protein, GAP-43. J Cell Biol 108: 613-624 Available: http://jcb.rupress.org/content/108/2/613.abstract. Accessed 30 April 2012.
43. Berger F, Lau C, Dahlmann M, Ziegler M, (2005) Subcellular compartmentation and differential catalytic properties of the three human nicotinamide mononucleotide adenylyltransferase isoforms. J Biol Chem 280: 36334-36341 Available: http://www.ncbi.nlm.nih.gov/pubmed/16118205.
44. Prescott GR, Gorleku OA, Greaves J, Chamberlain LH, (2009) Palmitoylation of the synaptic vesicle fusion machinery. J Neurochem 110: 1135-1149 Available: http://www3.interscience.wiley.com/journal/122440955/abstract.
45. Iwanaga T, Tsutsumi R, Noritake J, Fukata Y, Fukata M, (2009) Dynamic protein palmitoylation in cellular signaling. Prog Lipid Res 48: 117-127 Available: http://www.sciencedirect.com/science/article/pii/S0163782709000034. Accessed 13 January 2012.
46. Zhai Q, Wang J, Kim A, Liu Q, Watts R, et al. (2003) Involvement of the ubiquitin-proteasome system in the early stages of wallerian degeneration. Neuron 39: 217-225 Available: http://www.ncbi.nlm.nih.gov/pubmed/12873380.
47. Gao Z, Ni Y, Szabo G, Linden J, (1999) Palmitoylation of the recombinant human A1 adenosine receptor: enhanced proteolysis of palmitoylation-deficient mutant receptors. Biochem J 342: 387-395.
48. Percherancier Y, Planchenault T, Valenzuela-Fernandez a, Virelizier JL, Arenzana-Seisdedos F, et al. (2001) Palmitoylation-dependent control of degradation, life span, and membrane expression of the CCR5 receptor. J Biol Chem 276: 31936-31944 Available: http://www.ncbi.nlm.nih.gov/pubmed/11390405.
49. Gonnord P, Delarasse C, Auger R, Benihoud K, Prigent M, et al. (2009) Palmitoylation of the P2X7 receptor, an ATP-gated channel, controls its expression and association with lipid rafts. FASEB J 23: 795-805 Available: http://www.ncbi.nlm.nih.gov/pubmed/18971257.
50. Abrami L, Leppla SH, van der Goot FG, (2006) Receptor palmitoylation and ubiquitination regulate anthrax toxin endocytosis. J Cell Biol 172: 309-320 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2063559&tool=pmcentrez&rendertype=abstract. Accessed 21 March 2012.
51. Valdez-taubas J, Pelham H, (2005) Swf1-dependent palmitoylation of the SNARE Tlg1 prevents its ubiquitination and degradation. EMBO J 24: 2524-2532 Available: http://www.ncbi.nlm.nih.gov/pubmed/15973437.
52. Xiong X, Hao Y, Sun K, Li J, Li X, et al. (2012) The highwire ubiquitin ligase promotes axonal degeneration by tuning levels of Nmnat protein. PLoS Biol 10: e1001440 Available: http://dx.plos.org/10.1371/journal.pbio.1001440. Accessed 7 December 2012. doi:10.1371/journal.pbio.1001440.
53. Sherer NM, Lehmann MJ, Jimenez-Soto LF, Ingmundson A, Horner SM, et al. (2003) Visualization of retroviral replication in living cells reveals budding into multivesicular bodies. Traffic 4: 785-801 Available: http://www.ncbi.nlm.nih.gov/pubmed/14617360.
54. Bogdanov AM, Bogdanova EA, Chudakov DM, Gorodnicheva TV, Lukyanov S, et al. (2009) Cell culture medium affects GFP photostability: a solution. Nat Methods 6: 859-860 Available: http://www.nature.com/nmeth/journal/v6/n12/full/nmeth1209-859.html.
55. Andrews S, Gilley J, Coleman MP, (2010) Difference Tracker: ImageJ plugins for fully-automated analysis of multiple axonal transport parameters. J Neurosci Methods 193: 281-287 Available: http://www.ncbi.nlm.nih.gov/pubmed/20869987. Accessed 29 September 2010.
56. Gilley J, Seereeram A, Ando K, Mosely S, Andrews S, et al. (2012) Age-dependent axonal transport and locomotor changes and tau hypophosphorylation in a "P301L" tau knockin mouse. Neurobiol Aging 33: 621.e1-621.e15 Available: http://www.ncbi.nlm.nih.gov/pubmed/21492964. Accessed 6 March 2012.